Fuchs SY - Search Results

1

Tumor suppressor activities of the Fbw7 E3 ubiquitin ligase receptor.

Fuchs SY. Fuchs SY. Cancer Biol Ther. 2005 May;4(5):506-8. doi: 10.4161/cbt.4.5.1703. Epub 2005 May 5. Cancer Biol Ther. 2005. PMID: 15908780 Free article. Review.

2

Recognition of substrate and Skp1 by the Homologue of Slimb (HOS) ubiquitin ligase receptor D role of the F-box.

Herter JR, Fuchs SY. Herter JR, et al. Among authors: fuchs sy. Med Sci Monit. 2002 Aug;8(8):BR283-8. Med Sci Monit. 2002. PMID: 12165731

3

The role of ubiquitin-proteasome pathway in oncogenic signaling.

Fuchs SY. Fuchs SY. Cancer Biol Ther. 2002 Jul-Aug;1(4):337-41. Cancer Biol Ther. 2002. PMID: 12432242 Review.

4

Interaction of Epstein-Barr virus latent membrane protein 1 with SCFHOS/beta-TrCP E3 ubiquitin ligase regulates extent of NF-kappaB activation.

Tang W, Pavlish OA, Spiegelman VS, Parkhitko AA, Fuchs SY. Tang W, et al. Among authors: fuchs sy. J Biol Chem. 2003 Dec 5;278(49):48942-9. doi: 10.1074/jbc.M307962200. Epub 2003 Sep 30. J Biol Chem. 2003. PMID: 14523018 Free article.

5

SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor.

Kumar KG, Tang W, Ravindranath AK, Clark WA, Croze E, Fuchs SY. Kumar KG, et al. Among authors: fuchs sy. EMBO J. 2003 Oct 15;22(20):5480-90. doi: 10.1093/emboj/cdg524. EMBO J. 2003. PMID: 14532120 Free PMC article.

6

Negative regulation of prolactin receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligase.

Li Y, Kumar KG, Tang W, Spiegelman VS, Fuchs SY. Li Y, et al. Among authors: fuchs sy. Mol Cell Biol. 2004 May;24(9):4038-48. doi: 10.1128/MCB.24.9.4038-4048.2004. Mol Cell Biol. 2004. PMID: 15082796 Free PMC article.

7

Targeting beta-transducin repeat-containing protein E3 ubiquitin ligase augments the effects of antitumor drugs on breast cancer cells.

Tang W, Li Y, Yu D, Thomas-Tikhonenko A, Spiegelman VS, Fuchs SY. Tang W, et al. Among authors: fuchs sy. Cancer Res. 2005 Mar 1;65(5):1904-8. doi: 10.1158/0008-5472.CAN-04-2597. Cancer Res. 2005. PMID: 15753389

8

De-regulation of ubiquitin-dependent proteolysis and the pathogenesis of malignant melanoma.

Fuchs SY. Fuchs SY. Cancer Metastasis Rev. 2005 Jun;24(2):329-38. doi: 10.1007/s10555-005-1581-0. Cancer Metastasis Rev. 2005. PMID: 15986141 Review.

9

Cross-talk between APC/C and CBP/p300.

Liu J, Fuchs SY. Liu J, et al. Among authors: fuchs sy. Cancer Biol Ther. 2006 Jul;5(7):760-2. doi: 10.4161/cbt.5.7.3103. Epub 2006 Jul 13. Cancer Biol Ther. 2006. PMID: 16861917 Free article. Review.

10

Raf inhibitor stabilizes receptor for the type I interferon but inhibits its anti-proliferative effects in human malignant melanoma cells.

Kumar KG, Liu J, Li Y, Yu D, Thomas-Tikhonenko A, Herlyn M, Fuchs SY. Kumar KG, et al. Among authors: fuchs sy. Cancer Biol Ther. 2007 Sep;6(9):1437-41. doi: 10.4161/cbt.6.9.4569. Epub 2007 Jun 13. Cancer Biol Ther. 2007. PMID: 17873516 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters